Sanara MedTech Inc.
SMTI
$31.05
-$0.85-2.67%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 7.50% | 8.75% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.50% | 8.75% | |||
| Cost of Revenue | -0.83% | 6.28% | |||
| Gross Profit | 8.43% | 9.03% | |||
| SG&A Expenses | 5.14% | 9.03% | |||
| Depreciation & Amortization | -0.14% | 0.01% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.81% | 8.05% | |||
| Operating Income | 15.61% | 0.08% | |||
| Income Before Tax | 18.31% | -96.18% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 18.31% | -96.18% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.40% | -27.79% | |||
| Net Income | 18.44% | -98.62% | |||
| EBIT | 15.61% | 0.08% | |||
| EBITDA | 50.43% | 0.28% | |||
| EPS Basic | 18.92% | -97.52% | |||
| Normalized Basic EPS | -2.34% | -20.92% | |||
| EPS Diluted | 18.92% | -97.52% | |||
| Normalized Diluted EPS | -2.34% | -20.92% | |||
| Average Basic Shares Outstanding | 0.57% | 0.59% | |||
| Average Diluted Shares Outstanding | 0.57% | 0.59% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
